News Related to AbClon

Related coverage linked through entity extraction aliases.

Korean Biotechs to Present Next-Gen Cancer Therapies at AACR Meeting

Apr 08, 2026

Korean biotech firms will present next-generation cancer therapies at the AACR meeting, including CAR-T platforms for solid tumors, mRNA-based treatments, radiopharmaceuticals, and bispecific antibody ADCs. Companies like AbClon, Verismo Therapeutics, Hanmi Pharmaceutical, and SK Biopharmaceuticals will showcase their latest research.

In Vivo CAR-T Technology and Community Delivery Expand Cancer Treatment Access

Feb 28, 2026

Next-generation in vivo CAR-T therapy enables cancer treatment with a single injection, while new Texas legislation and community-based delivery models expand patient access to this advanced cellular therapy.